Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on‐off‐on design
- 11 December 2002
- journal article
- clinical trial
- Published by Wiley in Bipolar Disorders
- Vol. 4 (6) , 412-417
- https://doi.org/10.1034/j.1399-5618.2002.02228.x
Abstract
Rationale and Objectives: Carbamazepine has shown reasonable antimanic properties, but its use has been limited because of enzyme‐inducing effects. The keto‐derivative oxcarbazepine (OXC) is very si...Keywords
This publication has 26 references indexed in Scilit:
- Clinical Pharmacokinetics of Newer Antiepileptic DrugsClinical Pharmacokinetics, 1996
- Action of GP 47779, the Active Metabolite of Oxcarbazepine, on the Corticostriatal System. I. Modulation of Corticostriatal Synaptic TransmissionEpilepsia, 1995
- Oxcarbazepine: Preclinical Anticonvulsant Profile and Putative Mechanisms of ActionEpilepsia, 1994
- Oxcarbazepine: Mechanisms of ActionEpilepsia, 1994
- Oxcarbazepine: Pharmacokinetic Interactions and Their Clinical RelevanceEpilepsia, 1994
- Clinical Pharmacology and Pharmacokinetics of OxcarbazepineEpilepsia, 1994
- Clinical Experience with OxcarbazepineEpilepsia, 1994
- OxcarbazepineDrugs, 1992
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978